Marksans Pharma consolidated net profit declines 18.10% in the December 2021 quarter

Sales rise 1.19% to Rs 362.63 crore

Net profit of Marksans Pharma declined 18.10% to Rs 48.27 crore in the quarter ended December 2021 as against Rs 58.94 crore during the previous quarter ended December 2020. Sales rose 1.19% to Rs 362.63 crore in the quarter ended December 2021 as against Rs 358.36 crore during the previous quarter ended December 2020. ParticularsQuarter EndedDec. 2021Dec. 2020% Var.Sales362.63358.36 1 OPM %15.9425.41 -PBDT68.9186.22 -20 PBT60.3577.64 -22 NP48.2758.94 -18

Powered by Capital Market - Live News